From January 1, 2024 to March 18, 2024, the company has repurchased 286,400 shares, representing 0.16% for CNY 8.92 million. With this, the company has completed the repurchase of 1,285,600 shares, representing 0.71% for CNY 39.9 million under the buyback announced on September 15, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.03 CNY | +3.94% | +4.11% | +12.61% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.61% | 935M | |
+13.21% | 8.01B | |
-0.47% | 7.36B | |
+12.30% | 6.54B | |
-6.99% | 3.73B | |
-7.95% | 3.42B | |
-4.78% | 1.24B | |
-43.32% | 886M | |
-22.54% | 827M | |
-17.59% | 804M |
- Stock Market
- Equities
- 300791 Stock
- News Sirio Pharma Co., Ltd.
- Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.